Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats

Brain Research

Volumn 1307, Issue , 2010, Pages 158-165

  Wang, Cheng Fang ^a   Li, Dan Qing ^a   Xue, Hong Yu ^b   Hu, Bo ^c  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b SUZHOU UNIVERSITY   (China)

^c DALIAN UNIVERSITY   (China)

Author keywords

Catalpol; Cognitive function; Diabetic encephalopathy

Indexed keywords

CATALPOL; GLUCOSE; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ENCEPHALOPATHY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; MAZE TEST; NERVE INJURY; NEUROPATHOLOGY; NICK END LABELING; NISSL STAINING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SUPPLEMENTATION;

ADMINISTRATION, ORAL; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSIDES; GLUTATHIONE PEROXIDASE; IN SITU NICK-END LABELING; IRIDOIDS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MAZE LEARNING; NERVE GROWTH FACTOR; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TIME FACTORS;

RATTUS;

EID: 70749131115     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.10.034     Document Type: Article

References (34)

1. Awad N., Gagnon M., and Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J. Clin. Exp. Neuropsychol. 26 (2004) 1044-1080
2. Bae H.J., Lee Y.S., Kang D.W., Gu J.S., Yoon B.W., and Ron J.K. Neuroprotective effect of low dose riluzole in gerbil model of transient global ischemia. Neurosci. Lett. 294 (2000) 29-32
3. Baydas G., Canatan H., and Turkoglu A. Comparative analyses of the protective effects of melatonin and vitamin E on streptozotocin-induced diabetes mellitus. J. Pineal Res. 32 (2002) 225-230
4. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., and Gispen W.H. Place learning and hippocampal synaptic plasticityin streptozotocin-induced diabetic rats. Diabetes 45 (1996) 1259-1266
5. Biessels G.J., Staekenborg S., Brunner E., Brayne C., and Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5 (2006) 64-74
6. Bloomgarden Z.T. Diabetic Neuropathy. Diabetes Care 30 (2007) 1027-1032
7. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care 5 (2002) 561-568
8. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23 (2002) 599-622
9. Fukui K., Onodera K., Shinkai T., Suzuki S., and Urano S. Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems. Ann. N.Y. Acad. Sci. 928 (2001) 168-175
10. Greene D.A., Stevens M.J., Obrosova I., and Feldman E.L. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur. J. Pharmacol. 375 (1999) 217-223
11. Gupta R.K., Kesari A.N., Diwakar S., Tyagi A., Tandon V., Chandra R., and Watal G. In vivo evaluation of anti-oxidant and anti-lipidimic potential of Annona squamosa aqueous extract in Type 2 diabetic models. J. Ethnopharmacol. 118 (2008) 21-25
12. Jiang B., Zhang H., Bi J., and Zhang X.L. Neuroprotective activities of catalpol on MPP+/MPTP-induced neurotoxicity. Neurol. Res. 30 (2008) 639-644
13. Li D.Q., Bao Y.M., Zhao J.J., Liu C.P., Liu Y., and An L.J. Neuroprotective properties of catalpol in transient global cerebral ischemia in gerbils: dose-response, therapeutic time-window and long-term efficacy. Brain Res. 1029 (2004) 179-185
14. Li D.Q., Duan Y.L., Bao Y.M., Liu C.P., Liu Y., and An L.J. Neuroprotection of catalpol in transient global ischemia in gerbils. Neurosci. Res. 50 (2004) 169-177
15. Li D.Q., Li Y., Liu Y.X., Bao Y.M., Hu B., and An L.J. Catalpol prevents the loss of CA1 hippocampal neurons and reduces working errors in gerbils after ischemia-reperfusion injury. Toxicon 46 (2005) 845-851
16. Li D.Q., Bao Y.M., Li Y., Wang C.F., Liu Y., and An L.J. Catalpol modulates the expressions of Bcl-2 and Bax, attenllates apoptosis in gerbils after is chemic injury. Brain Res. 1115 (2006) 179-185
17. Lupien S.B., Bluhm E.J., and Ishii D.N. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. J. Neurosci. Res. 74 (2003) 512-523
18. Mastrocola R., Restivo F., Vercellinatto I., Danni O., Brignardello E., Aragno M., and Boccuzzi G. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J. Endocrinol. 187 (2005) 37-44
19. Mijnhout G.S., Scheltens P., Diamant M., Biessels G.J., Wessels A.M., Simsek S., Snoek F.J., and Heine R.J. Diabetic encephalopathy: a concept in need of a definition. Diabetologia 49 (2006) 1447-1448
20. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
21. Ott A., Stolk R.P., Van Harskamp F., Pols H.A., Hofinan A., and Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53 (1999) 1937-1942
22. Ozkaya Y.G., Agar A., Yargicoglu P., Hacioglu G., Bilmen-Sarikçioglu S., Ozen I., and Alicigüzel Y. The effect of exercise on brain antioxidant status of diabetic rats. Diabetes Metab. 28 (2002) 377-384
23. Popovic M., Biessels G.J., Isaacson R.L., and Gispen W.H. Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task. Behav. Brain Res. 122 (2001) 201-207
24. Qi X.Y., Chen W.J., Zhang L.Q., and Xie B.J. Mogrosides extract from Siraitia grosvenori scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice. Nutr. Res. 28 (2008) 278-284
25. Reaven G.M., Thomson L.W., Nahum D., and Haskins E. Relationship between hyperglycaemia and cognitive functions in older NIDDM patients. Diabetes Care 13 (1990) 16-21
26. Ryan C.M., Williams T.M., Finegold D.N., and Orchard T.J. Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 36 (1993) 329-334
27. Sinclair A.J., Girling A.J., and Bayer A.J. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res. Clin. Pract. 50 (2000) 203-212
28. Somfai G.M., Knippel B., Ruzicska E., Stadler K., Toth M., Salacz G., Magyar K., and Somogyi A. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Neurochem. Int. 48 (2006) 746-752
29. Stewart R., and Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. Med. 16 (1999) 93-112
30. Strachan M.W.J., Deary I.J., Ewing F.M.E., and Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20 (1997) 438-445
31. Tuzcu M., and Baydas G. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur. J. Pharmacol. 537 (2006) 106-110
32. Wohaieb S.A., and Godin D.V. Alterations in free radical tissue-defence mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 36 (1987) 1014-1018
33. Xue H., Jin L., Jin L., Zhang P., Li D., Xia Y., Lu Y., and Xu Y. Neuroprotection of aucubin in primary diabetic encephalopathy. Sci. China. C, Life Sci. 51 (2008) 495-502
34. Zigler J.S., and Hess H.H. Evidence of initiation by lipid peroxidation products. Exp. Eye Res. 41 (1985) 67-76